Comparative hemodynamic effects of OPC-18790 and dobutamine in patients with advanced heart failure

This publication has 11 references indexed in Scilit:

• Effects of Vesnarinone on Morbidity and Mortality in Patients with Heart Failure
  New England Journal of Medicine, 1993
• Cardiovascular actions of OPC-18790: A novel positive inotropic agent with little chronotropic action
  Heart and Vessels, 1992
• Comparison of intravenous amrinone and dobutamine in congestive heart failure due to idiopathic dilated cardiomyopathy
  The American Journal of Cardiology, 1990
• Arrhythmias Associated with Intermittent Outpatient Dobutamine Infusion
  Angiology, 1986
• Beneficial effect of OPC-8212 (3,4-dihydro-6-(4-(3,4-dimethoxybenzoyl)-1-piperazinyl)-2(1H)-quinolinone) on myocardial oxygen consumption in dogs with ischemic heart failure.
  Japanese Circulation Journal, 1986
• Evidence for possible increase of sodium channel open time and involvement of Na/Ca exchange by a new positive inotropic drug: OPC-8212
  European Journal of Pharmacology, 1985
• Clinical effects and side effects of amrinone. A study of 24 patients with chronic congestive heart failure
  Archives of internal medicine (1960), 1985
• Tolerance to dobutamine after a 72 hour continuous infusion
  The American Journal of Medicine, 1980
• Comparative responses to dobutamine and nitroprusside in patients with chronic low output cardiac failure.
  Circulation, 1977
• Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure.
  Circulation, 1977